SLI
1.999,82
PKT
-10,92
PKT
-0,54
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.06.17 | Roche Reduce | HSBC | |
| 02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.06.17 | Novartis Underweight | Barclays Capital | |
| 02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.06.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 01.06.17 | Novartis buy | Jefferies & Company Inc. | |
| 26.05.17 | Nestlé buy | UBS AG | |
| 26.05.17 | UBS verkaufen | S&P Capital IQ | |
| 25.05.17 | UBS kaufen | Barclays Capital | |
| 25.05.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.05.17 | Novartis Neutral | UBS AG | |
| 24.05.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 23.05.17 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 23.05.17 | UBS Neutral | JP Morgan Chase & Co. | |
| 23.05.17 | Holcim buy | Deutsche Bank AG | |
| 23.05.17 | Holcim Outperform | Bernstein Research | |
| 22.05.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 22.05.17 | Holcim market-perform | Bernstein Research | |
| 22.05.17 | Swiss Re market-perform | Bernstein Research | |
| 19.05.17 | Roche overweight | Barclays Capital | |
| 19.05.17 | Roche overweight | Barclays Capital | |
| 19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.05.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.05.17 | Roche overweight | JP Morgan Chase & Co. | |
| 17.05.17 | UBS buy | Goldman Sachs Group Inc. | |
| 17.05.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.05.17 | ABB (Asea Brown Boveri) Outperform | Robert W. Baird & Co. Incorporated | |
| 16.05.17 | Zurich Insurance kaufen | DZ BANK | |
| 16.05.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 15.05.17 | Zurich Insurance Equal-Weight | Morgan Stanley | |
| 15.05.17 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
| 12.05.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 12.05.17 | Novartis buy | Jefferies & Company Inc. | |
| 12.05.17 | Roche buy | Jefferies & Company Inc. | |
| 12.05.17 | Richemont Hold | Baader Bank | |
| 12.05.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.05.17 | Novartis Underweight | Morgan Stanley | |
| 12.05.17 | Roche overweight | Morgan Stanley | |
| 11.05.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. |